HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 177 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 1.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $1,538,000 | -30.2% | 120,000 | -29.4% | 0.22% | -36.7% |
| Q1 2017 | $2,203,000 | +23.9% | 170,000 | -5.6% | 0.35% | +2.3% |
| Q4 2016 | $1,778,000 | -99.9% | 180,000 | -28.0% | 0.34% | -29.0% |
| Q3 2016 | $3,020,000,000 | +139844.4% | 250,000 | 0.0% | 0.48% | +25.3% |
| Q2 2016 | $2,158,000 | -47.1% | 250,000 | -42.0% | 0.38% | -52.7% |
| Q1 2016 | $4,082,000 | -42.5% | 431,000 | +5.1% | 0.81% | -24.6% |
| Q4 2015 | $7,105,000 | +207.6% | 410,000 | +138.4% | 1.07% | +191.8% |
| Q3 2015 | $2,310,000 | -40.5% | 172,000 | 0.0% | 0.37% | -21.0% |
| Q2 2015 | $3,884,000 | – | 172,000 | – | 0.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SNYDER CAPITAL MANAGEMENT L P | 4,324,232 | $165,185,662 | 3.73% |
| Steamboat Capital Partners, LLC | 196,898 | $7,521,504 | 2.79% |
| 2Xideas AG | 600,799 | $22,950,522 | 2.54% |
| BERNZOTT CAPITAL ADVISORS | 171,808 | $6,563,066 | 2.26% |
| Redwood Investments, LLC | 328,459 | $12,547,134 | 1.70% |
| Mesirow Institutional Investment Management, Inc. | 380,415 | $14,531,853 | 1.47% |
| Granite Investment Partners, LLC | 856,253 | $32,708,865 | 1.37% |
| Penn Capital Management Company, LLC | 324,707 | $12,453,211 | 1.28% |
| EFG Asset Management (North America) Corp. | 137,739 | $5,262,319 | 1.25% |
| First Light Asset Management, LLC | 313,536 | $11,977,075 | 1.14% |